Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Metolazone As Early Add On Therapy For Acute Decompensated Heart Failure (MELT-HF)--A Single Center Pilot Study.

NCT02620384 is registered in ClinicalTrials.gov with Aultman Health Foundation as lead sponsor.

NCT NCT02620384
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02620384 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Metolazone As Early Add On Therapy For Acute Decompensated Heart Failure (MELT-HF)--A Single Center Pilot Study.
Lead sponsor
Aultman Health Foundation
Phase
Phase 3
Overall status
Terminated
Start date
October 1, 2015
Completion date
December 29, 2017
Enrollment
147 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute decompensated heart failure